Post-earnings recap
Reported
Fri, Nov 14, 2025
EPS actual
$-0.45
EPS est.
$-0.40
EPS surprise
-12.50%
1-day move
-10.13%
Twist Bioscience's earnings report reflects ongoing challenges, particularly with their EPS falling short of expectations. The stock reacted negatively, dropping 10.13%, likely due to investor concerns about the company's current performance and lack of guidance. Without clear direction from management, investors may remain cautious in the near term.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.45 | N/A | -12.50% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concern over current market conditions and indicated that adjustments are necessary to improve performance.
Management acknowledged the challenges faced during the quarter.
They emphasized the need for strategic adjustments moving forward.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—